✦ LIBER ✦

Pharmacodynamic considerations in the treatment of moderate to severe pseudomonal infections with cefepime

✍ Scribed by Ambrose, P. G.

Book ID: 124165531
Publisher: Oxford University Press
Year: 2002
Tongue: English
Weight: 139 KB
Volume: 49
Category: Article
ISSN: 0305-7453
DOI: 10.1093/jac/49.3.445

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and safety of cefepime treatmen

Efficacy and safety of cefepime treatment in Chinese patients with severe bacterial infections: in comparison with ceftazidime treatment

✍ Shan-Chwen Chang; Chi-Tai Fang; Po-Ren Hsueh; Chieh-Ju Liu; Wang-Huei Sheng; Szu 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 69 KB

Efficacy and safety of cefepime treatmen

Efficacy and safety of cefepime treatment in Chinese patients with severe bacterial infections: in comparison with ceftazidime treatment

✍ Shan-Chwen Chang; Chi-Tai Fang; Po-Ren Hsueh; Chieh-Ju Liu; Wang-Huei Sheng; Szu 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 69 KB

An open label, randomized comparative study was conducted to evaluate the safety and efficacy of cefepime, in comparison with ceftazidime, in the treatment of adult hospitalized Chinese patients with severe bacterial infections. Forty patients with severe infections including septicemia, urinary tra

Peritoneal pharmacokinetics of cefepime

Peritoneal pharmacokinetics of cefepime in laparotomy patients with inflammatory bowel disease, and dosage considerations for surgical intra-abdominal infections based on pharmacodynamic assessment

✍ Kazuko Higuchi; Kazuro Ikawa; Kayo Ikeda; Hiroki Ohge; Taijiro Sueda; Hitoshi Ho 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 292 KB

The safety of ustekinumab treatment in p

The safety of ustekinumab treatment in patients with moderate-to-severe psoriasis and latent tuberculosis infection

✍ Tsai, T.-F.; Ho, V.; Song, M.; Szapary, P.; Kato, T.; Wasfi, Y.; Li, S.; Shen, Y 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 175 KB

Post-treatment Leukocytosis Predicts an

Post-treatment Leukocytosis Predicts an Unfavorable Clinical Response in Patients with Moderate to Severe Diabetic Foot Infections

✍ Adam E. Fleischer; James S. Wrobel; Andrea Leonards; Scott Berg; Daniel P. Evans 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 284 KB

Infliximab in the treatment of moderate

Infliximab in the treatment of moderate to severe atopic dermatitis

✍ Arnd Jacobi; Christian Antoni; Bernhard Manger; Gerold Schuler; Michael Hertl 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 184 KB